SSY Group Limited (HKG:2005)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Materials	377.42M	405.07M	387.45M	350.84M	356.62M
Intravenous Infusion Solution and Others	3.97B	5.59B	6.30B	6.27B	5.21B
Inter-Segment Revenue	-182.24M	-216.91M	-225.82M	-	-
Unallocated	-	-	-	-182.20M	-208.68M
Total	4.17B	5.77B	6.46B	6.43B	5.36B

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other Countries	700.74M	724.61M	661.64M	891.78M	480.80M
The People's Republic of China	3.46B	5.05B	5.80B	5.54B	4.88B
Total	4.17B	5.77B	6.46B	6.43B	5.36B

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 30, 2026

Data Sources Report a data error